BD offers the BD Veritor™ line of immunoassay products - the BD Veritor system and the BD Veritor Plus system - which give objective, lab-quality test results within minutes to healthcare providers and laboratorians in near-patient settings.

The point-of-care systems have waived status under the Clinical Laboratory Improvement Amendments of 1988 for rapid detection of influenza A and B. The systems eliminate the subjectivity of visual interpretation of test results by providing objective digital results. The systems can also help detect infectious diseases such as respiratory syncytial virus (RSV) and group A strep, and enable providers to review patient results while the patient is still on site, and to make earlier intervention decisions.

Visit www.bd.com for more information and video demonstrations.